Ariadne Diagnostics' Seed Round

Ariadne Diagnostics raised a round of funding on January 15, 2014. Investors include Maryland Technology Development Corporation.

Ariadne Diagnostics is a molecular diagnostic company focused on discovery and development of companion diagnostic tests in areas of oncology and rare neuromuscular/neurodegenerative diseases.…

Articles about Ariadne Diagnostics' Seed Round: